JPWO2021076564A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021076564A5 JPWO2021076564A5 JP2022522657A JP2022522657A JPWO2021076564A5 JP WO2021076564 A5 JPWO2021076564 A5 JP WO2021076564A5 JP 2022522657 A JP2022522657 A JP 2022522657A JP 2022522657 A JP2022522657 A JP 2022522657A JP WO2021076564 A5 JPWO2021076564 A5 JP WO2021076564A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- cdr2
- cdr3
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962915123P | 2019-10-15 | 2019-10-15 | |
US62/915,123 | 2019-10-15 | ||
PCT/US2020/055497 WO2021076564A1 (en) | 2019-10-15 | 2020-10-14 | Proteins binding nkg2d, cd16 and flt3 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022551969A JP2022551969A (ja) | 2022-12-14 |
JPWO2021076564A5 true JPWO2021076564A5 (xx) | 2023-10-19 |
Family
ID=75538862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022522657A Pending JP2022551969A (ja) | 2019-10-15 | 2020-10-14 | Nkg2d、cd16およびflt3に結合するタンパク質 |
Country Status (16)
Country | Link |
---|---|
US (1) | US20240117054A1 (xx) |
EP (1) | EP4045538A1 (xx) |
JP (1) | JP2022551969A (xx) |
KR (1) | KR20220083770A (xx) |
CN (1) | CN115298217A (xx) |
AR (1) | AR120223A1 (xx) |
AU (1) | AU2020368163A1 (xx) |
BR (1) | BR112022007128A2 (xx) |
CA (1) | CA3153858A1 (xx) |
CL (1) | CL2022000928A1 (xx) |
CO (1) | CO2022004757A2 (xx) |
IL (1) | IL292261A (xx) |
MX (1) | MX2022004430A (xx) |
PE (1) | PE20221316A1 (xx) |
TW (1) | TW202128759A (xx) |
WO (1) | WO2021076564A1 (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2020008336A (es) | 2018-02-08 | 2020-09-21 | Dragonfly Therapeutics Inc | Dominios variables de anticuerpos que se dirigen al receptor nkg2d. |
CA3226178A1 (en) * | 2021-08-24 | 2023-03-02 | Jiangyu YAN | Gdf15 fusion proteins and uses thereof |
EP4408896A1 (en) * | 2021-09-29 | 2024-08-07 | Dragonfly Therapeutics, Inc. | Proteins binding nkg2d, cd16 and baff-r |
US20230203202A1 (en) * | 2021-12-08 | 2023-06-29 | Dragonfly Therapeutics, Inc. | Proteins binding nkg2d, cd16 and 5t4 |
WO2024040195A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
WO2024102693A2 (en) | 2022-11-07 | 2024-05-16 | Xencor, Inc. | Il-18-fc fusion proteins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL2014108B1 (en) * | 2015-01-09 | 2016-09-30 | Aduro Biotech Holdings Europe B V | Altered april binding antibodies. |
WO2017011803A1 (en) * | 2015-07-16 | 2017-01-19 | Cellerant Therapeutics, Inc. | Cysteine-substituted immunoglobulins |
BR112020001972A2 (pt) * | 2017-07-31 | 2020-08-04 | Dragonfly Therapeutics, Inc. | proteínas de ligação a nkg2d, cd16 e flt3 |
-
2020
- 2020-10-14 AR ARP200102840A patent/AR120223A1/es unknown
- 2020-10-14 AU AU2020368163A patent/AU2020368163A1/en active Pending
- 2020-10-14 JP JP2022522657A patent/JP2022551969A/ja active Pending
- 2020-10-14 KR KR1020227016160A patent/KR20220083770A/ko unknown
- 2020-10-14 US US17/769,160 patent/US20240117054A1/en active Pending
- 2020-10-14 PE PE2022000621A patent/PE20221316A1/es unknown
- 2020-10-14 BR BR112022007128A patent/BR112022007128A2/pt unknown
- 2020-10-14 CA CA3153858A patent/CA3153858A1/en active Pending
- 2020-10-14 EP EP20876627.9A patent/EP4045538A1/en active Pending
- 2020-10-14 WO PCT/US2020/055497 patent/WO2021076564A1/en unknown
- 2020-10-14 TW TW109135528A patent/TW202128759A/zh unknown
- 2020-10-14 MX MX2022004430A patent/MX2022004430A/es unknown
- 2020-10-14 CN CN202080072319.9A patent/CN115298217A/zh active Pending
-
2022
- 2022-04-12 CL CL2022000928A patent/CL2022000928A1/es unknown
- 2022-04-13 IL IL292261A patent/IL292261A/en unknown
- 2022-04-13 CO CONC2022/0004757A patent/CO2022004757A2/es unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brinkmann et al. | The making of bispecific antibodies | |
JP2021098732A5 (xx) | ||
JP2020531438A5 (ja) | Nkg2d、cd16、およびhla−eに結合するタンパク質 | |
JP2021098733A5 (xx) | ||
US8796424B2 (en) | Tri- or tetraspecific antibodies | |
IL261674A (en) | Protein-like binding proteins with a double variable region have a cross-linking region direction | |
JP2020533311A5 (ja) | NKG2D、CD16およびNectin4に結合するタンパク質 | |
JP2018537966A5 (xx) | ||
RU2021110369A (ru) | Белки, связывающие nkg2d, cd16 и опухолеассоциированный антиген | |
MX2011010159A (es) | Anticuerpos multiespecificos que comprenden anticuerpos de longitud completa y fragmentos fab de cadena sencilla. | |
JP2023052214A5 (xx) | ||
WO2010112194A1 (en) | Antigen-binding polypeptides and multispecific antibodies comprising them | |
JP2023106433A5 (xx) | ||
JP2021507698A5 (xx) | ||
JPWO2020033702A5 (xx) | ||
Spasevska | An outlook on bispecific antibodies: Methods of production and therapeutic benefits | |
JPWO2022102768A5 (xx) | ||
JPWO2019157366A5 (xx) | ||
JPWO2021076564A5 (xx) | ||
JP2021094022A5 (xx) | ||
JPWO2021064137A5 (xx) | ||
JPWO2022042488A5 (xx) | ||
JPWO2020033587A5 (xx) | ||
IL311617A (en) | NKG2D, CD16 and BAFF-R binding proteins | |
CA3207821A1 (en) | Orthogonal mutations for heterodimerization |